Sofia Ahmed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sofia Ahmed has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Ali Sheraz
Department of Pharmaceutics, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
40 shared publications - Iqbal Ahmad
Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
31 shared publications - Zubair Anwar
Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
19 shared publications Tania Mirza
Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
11 shared publicationsSadia Hafeez Kazi
Department of Pharmaceutics, Baqai Institute of Pharmaceutical Sciences, Baqai Medical University, Karachi, Pakistan
8 shared publicationsRaheela Bano
Dow College of Pharmacy, Dow University of Health Sciences (Ojha Campus), Karachi, Pakistan
7 shared publications
Latest Publications
- 29 April 2026
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 23 (5) , 120
Thermal degradation kinetics of tolfenamic acid in liquid media: a combined experimental and QSPR–machine learning study
- 29 April 2026
- Published by Springer Nature in Journal of the Iranian Chemical Society
- Vol. 23 (5) , 120
Thermal degradation kinetics of tolfenamic acid in liquid media: a combined experimental and QSPR–machine learning study
- 1 January 2026
- Published by Bentham Science Publishers Ltd. in Anti-Infective Agents
- Vol. 24 (1)
Spectrofluorimetric and Spectrophotometric Methods for the Determination of Ciprofloxacin HCl and Their Comparison with the Compendial High-Performance Liquid Chromatography (HPLC) Method
Introduction: Ciprofloxacin hydrochloride (CH) is a widely used fluoroquinolone antibiotic. Accurate, cost-effective methods are essential for its routine quality control. This study aimed to develop and validate simple UV spectrophotometric and spectrofluorimetric methods for quantifying CH in bulk and pharmaceutical formulations. Methods: UV analysis was performed at 271 nm, while fluorescence measurements were taken at 335 nm (excitation) and 416 nm (emission) in phosphate buffer (pH 7). Validation was conducted in accordance with the International Council for Harmonisation (ICH) guidelines for linearity, accuracy, precision, Limit of Detection (LOD), Limit of Quantification (LOQ), robustness, and solution stability. Results were compared with an official HPLC method. Results: Both methods demonstrated excellent linearity in the range of 0.4-2.0 × 10⁻⁵ M (r² = 0.9999). The limits of detection (LOD) and quantification (LOQ) were 0.64/1.95 × 10⁻⁶ M for the UV method and 0.66/1.99 × 10⁻⁶ M for the fluorescence method. Recovery values ranged from 99.27% to 99.92% (UV) and 98.60% to 100.32% (fluorescence), with %RSD values below 2%, indicating good precision. Robustness testing revealed minimal effects from deliberate variations in experimental conditions, and the results showed strong agreement with the compendial HPLC method Discussion: UV spectrophotometric and spectrofluorimetric methods proved to be accurate, sensitive, and reproducible. The UV method is ideal for basic lab setups, while fluorescence offers greater sensitivity for lower concentrations. Comparable results with HPLC confirm their suitability. Conclusion: Validated UV and fluorescence methods provide efficient, accurate, and lowcost alternatives to HPLC for quality control of CH in pharmaceutical analysis.
- 1 January 2026
- Published by Bentham Science Publishers Ltd. in Anti-Infective Agents
- Vol. 24 (1)
Spectrofluorimetric and Spectrophotometric Methods for the Determination of Ciprofloxacin HCl and Their Comparison with the Compendial High-Performance Liquid Chromatography (HPLC) Method
Introduction: Ciprofloxacin hydrochloride (CH) is a widely used fluoroquinolone antibiotic. Accurate, cost-effective methods are essential for its routine quality control. This study aimed to develop and validate simple UV spectrophotometric and spectrofluorimetric methods for quantifying CH in bulk and pharmaceutical formulations. Methods: UV analysis was performed at 271 nm, while fluorescence measurements were taken at 335 nm (excitation) and 416 nm (emission) in phosphate buffer (pH 7). Validation was conducted in accordance with the International Council for Harmonisation (ICH) guidelines for linearity, accuracy, precision, Limit of Detection (LOD), Limit of Quantification (LOQ), robustness, and solution stability. Results were compared with an official HPLC method. Results: Both methods demonstrated excellent linearity in the range of 0.4-2.0 × 10⁻⁵ M (r² = 0.9999). The limits of detection (LOD) and quantification (LOQ) were 0.64/1.95 × 10⁻⁶ M for the UV method and 0.66/1.99 × 10⁻⁶ M for the fluorescence method. Recovery values ranged from 99.27% to 99.92% (UV) and 98.60% to 100.32% (fluorescence), with %RSD values below 2%, indicating good precision. Robustness testing revealed minimal effects from deliberate variations in experimental conditions, and the results showed strong agreement with the compendial HPLC method Discussion: UV spectrophotometric and spectrofluorimetric methods proved to be accurate, sensitive, and reproducible. The UV method is ideal for basic lab setups, while fluorescence offers greater sensitivity for lower concentrations. Comparable results with HPLC confirm their suitability. Conclusion: Validated UV and fluorescence methods provide efficient, accurate, and lowcost alternatives to HPLC for quality control of CH in pharmaceutical analysis.
- Open Access
- 18 November 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (53) , 45799-45821
Riboflavin-sensitized photoinduced degradation of donepezil hydrochloride: kinetic and computational insights for pharmaceutical formulation
Donepezil (DPZ) photosensitized degradation by riboflavin (RF) at pH 2.0–12.0 has been carried out in aerobic and anaerobic conditions under UV and visible irradiation to give an idea to pharmaceutical formulators to develop a stable co-formulation to administer to elderly patients with neurodegenerative diseases (Alzheimer's disease, Parkinson's disease). The photolysis rate constants (kobs) in aerobic and anaerobic conditions in the presence of RF (0.1–0.5 × 10−4 M) range from 0.25–11.5 and 0.025–1.120 × 10−2 min−1, respectively. RF catalyzes the photodegradation of DPZ, and the second-order (k2) constants in aerobic and anaerobic conditions range from 0.32 to 8.22 and 0.032 to 0.805 × 10−2 M−1 min−1, respectively, indicating that with an increase in the concentrations of RF, the rate of photolysis of DPZ also increases. The k-pH profile shows a bell-shaped curve from pH 2.0 to 4.0 and from pH 5.0 to 12.0, forming a sigmoid curve. The two-component spectrometric and HPLC green methods have been developed and validated for estimating DPZ and RF in pure and degraded solutions. Additionally, computational studies have been conducted to assess the formation of the ground-state complex, binding affinity, and molecular interactions between DPZ and RF.
- 18 November 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (53) , 45799-45821
Open AccessRiboflavin-sensitized photoinduced degradation of donepezil hydrochloride: kinetic and computational insights for pharmaceutical formulation
Donepezil (DPZ) photosensitized degradation by riboflavin (RF) at pH 2.0–12.0 has been carried out in aerobic and anaerobic conditions under UV and visible irradiation to give an idea to pharmaceutical formulators to develop a stable co-formulation to administer to elderly patients with neurodegenerative diseases (Alzheimer's disease, Parkinson's disease). The photolysis rate constants (kobs) in aerobic and anaerobic conditions in the presence of RF (0.1–0.5 × 10−4 M) range from 0.25–11.5 and 0.025–1.120 × 10−2 min−1, respectively. RF catalyzes the photodegradation of DPZ, and the second-order (k2) constants in aerobic and anaerobic conditions range from 0.32 to 8.22 and 0.032 to 0.805 × 10−2 M−1 min−1, respectively, indicating that with an increase in the concentrations of RF, the rate of photolysis of DPZ also increases. The k-pH profile shows a bell-shaped curve from pH 2.0 to 4.0 and from pH 5.0 to 12.0, forming a sigmoid curve. The two-component spectrometric and HPLC green methods have been developed and validated for estimating DPZ and RF in pure and degraded solutions. Additionally, computational studies have been conducted to assess the formation of the ground-state complex, binding affinity, and molecular interactions between DPZ and RF.
- Open Access
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
PEGylated chitosan xerogels for localized periodontal therapy: design, characterization, and drug release
It is essential to adopt effective therapy strategies for periodontal diseases to achieve optimal results while avoiding adverse effects on the system. This study has developed various PEGylated chitosan-based biodegradable xerogels for localized release of doxycycline hyclate (DH) to treat periodontal infectious diseases. The xerogels were formulated using the solvent casting method, and the solvent (0.25 M HCl) was slowly evaporated at ambient conditions. Two different molecular weights were employed for chitosan and polyethylene glycol, and twelve combinations, including the placebos and controls, were prepared for the formulation of xerogels. Different physical and chemical characteristics of the prepared DH xerogels were studied, such as drying time and rate, thickness, moisture content, swelling index, organoleptic characteristics, scanning electron microscopy, FTIR spectrometry, differential scanning calorimetry, drug release and kinetics, and antibacterial activity. The results revealed that the drug transforms from a crystalline to an amorphous state, thus rapidly releasing the drug (> 60% in 30 min. in all xerogels), followed by a sustained release up to 10 h. The release kinetics results revealed that the drug followed the Korsmeyer–Peppas model. It is concluded that the formulated DH-loaded xerogels showed promising results for use in the periodontal pockets to treat various infectious diseases.
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
Open AccessPEGylated chitosan xerogels for localized periodontal therapy: design, characterization, and drug release
It is essential to adopt effective therapy strategies for periodontal diseases to achieve optimal results while avoiding adverse effects on the system. This study has developed various PEGylated chitosan-based biodegradable xerogels for localized release of doxycycline hyclate (DH) to treat periodontal infectious diseases. The xerogels were formulated using the solvent casting method, and the solvent (0.25 M HCl) was slowly evaporated at ambient conditions. Two different molecular weights were employed for chitosan and polyethylene glycol, and twelve combinations, including the placebos and controls, were prepared for the formulation of xerogels. Different physical and chemical characteristics of the prepared DH xerogels were studied, such as drying time and rate, thickness, moisture content, swelling index, organoleptic characteristics, scanning electron microscopy, FTIR spectrometry, differential scanning calorimetry, drug release and kinetics, and antibacterial activity. The results revealed that the drug transforms from a crystalline to an amorphous state, thus rapidly releasing the drug (> 60% in 30 min. in all xerogels), followed by a sustained release up to 10 h. The release kinetics results revealed that the drug followed the Korsmeyer–Peppas model. It is concluded that the formulated DH-loaded xerogels showed promising results for use in the periodontal pockets to treat various infectious diseases.
- 4 November 2024
- Published by Elsevier
- Vol. 50, 183-227
Cyclodextrins and their applications in pharmaceutical and related fields
- 4 November 2024
- Published by Elsevier
- Vol. 50, 183-227
Cyclodextrins and their applications in pharmaceutical and related fields
- Open Access
- 5 July 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (30) , 21383-21397
Photolysis of tolfenamic acid in aqueous and organic solvents: a kinetic study
Tolfenamic acid (TA) is a non-steroidal anti-inflammatory drug that was studied for its photodegradation in aqueous (pH 2.0–12.0) and organic solvents (acetonitrile, methanol, ethanol, 1-propanol, 1-butanol). TA follows first-order kinetics for its photodegradation, and the apparent first-order rate constants (kobs) are in the range of 0.65 (pH 12.0) to 6.94 × 10−2 (pH 3.0) min−1 in aqueous solution and 3.28 (1-butanol) to 7.69 × 10−4 (acetonitrile) min−1 in organic solvents. The rate-pH profile for TA photodegradation is an inverted V (∧) or V-top shape, indicating that the cationic form is more susceptible to acid hydrolysis than the anionic form of TA, which is less susceptible to alkaline hydrolysis. The fluorescence behavior of TA also exhibits a V-top-shaped curve, indicating maximum fluorescence intensity at pH 3.0. TA is highly stable at a pH range of 5.0–7.0, making it suitable for formulation development. In organic solvents, the photodegradation rate of TA increases with the solvent's dielectric constant and solvent acceptor number, indicating solute–solvent interactions. The values of kobs decreased with increased viscosity of the solvents due to diffusion-controlled processes. The correlation between kobs versus ionization potential and solvent density has also been established. A total of 17 photoproducts have been identified through LC-MS, of which nine have been reported for the first time. It has been confirmed through electron spin resonance (ESR) spectrometry that the excited singlet state of TA is converted into an excited triplet state through intersystem crossing, which results in an increased rate of photodegradation in acetonitrile.
- 5 July 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (30) , 21383-21397
Open AccessPhotolysis of tolfenamic acid in aqueous and organic solvents: a kinetic study
Tolfenamic acid (TA) is a non-steroidal anti-inflammatory drug that was studied for its photodegradation in aqueous (pH 2.0–12.0) and organic solvents (acetonitrile, methanol, ethanol, 1-propanol, 1-butanol). TA follows first-order kinetics for its photodegradation, and the apparent first-order rate constants (kobs) are in the range of 0.65 (pH 12.0) to 6.94 × 10−2 (pH 3.0) min−1 in aqueous solution and 3.28 (1-butanol) to 7.69 × 10−4 (acetonitrile) min−1 in organic solvents. The rate-pH profile for TA photodegradation is an inverted V (∧) or V-top shape, indicating that the cationic form is more susceptible to acid hydrolysis than the anionic form of TA, which is less susceptible to alkaline hydrolysis. The fluorescence behavior of TA also exhibits a V-top-shaped curve, indicating maximum fluorescence intensity at pH 3.0. TA is highly stable at a pH range of 5.0–7.0, making it suitable for formulation development. In organic solvents, the photodegradation rate of TA increases with the solvent's dielectric constant and solvent acceptor number, indicating solute–solvent interactions. The values of kobs decreased with increased viscosity of the solvents due to diffusion-controlled processes. The correlation between kobs versus ionization potential and solvent density has also been established. A total of 17 photoproducts have been identified through LC-MS, of which nine have been reported for the first time. It has been confirmed through electron spin resonance (ESR) spectrometry that the excited singlet state of TA is converted into an excited triplet state through intersystem crossing, which results in an increased rate of photodegradation in acetonitrile.
- 1 March 2021
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1228, 129441
Photochemical interaction of cyanocobalamin and hydroxocobalamin with cysteine
- 1 March 2021
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1228, 129441
Photochemical interaction of cyanocobalamin and hydroxocobalamin with cysteine
- 17 May 2020
- Published by Wiley in Luminescence
- Vol. 35 (7) , 1017-1027
Development and validation of a spectrofluorimetric method for the analysis of tolfenamic acid in pure and tablet dosage form
Tolfenamic acid (TA) is commonly used in humans and animals because of its anti‐inflammatory, antipyretic, and analgesic effects. So far, no study has been carried out to develop a validated spectrofluorimetric method for determination of TA. Therefore, the present study aimed to develop and validate a simple, accurate, rapid, economical, and precise spectrofluorimetric method to assay TA in its pure and dosage forms, and also in degraded solutions. The fluorimetric method had higher sensitivity compared with the spectrophotometric and high‐performance liquid chromatography methods and could determine the drug at the microgram level. Optimum pH of TA for maximum fluorescence intensity was 3, and its two pKa values were calculated as 1.95 and 4.05. The proposed method was validated according to the guidelines of the International Council for Harmonisation, and parameters such as linearity, range, accuracy, precision, sensitivity, robustness, specificity, and solution stability were tested. Stress‐induced degradation studies on TA did not affect the accuracy and precision of the proposed method. The results obtained indicated that the method was linear over the concentration range 0.2–0.9 × 10−3 M with good accuracy, precision, and robustness for assay of TA in its pure and its tablet dosage forms and was comparable statistically with the British Pharmacopoeia method.
- 17 May 2020
- Published by Wiley in Luminescence
- Vol. 35 (7) , 1017-1027
Development and validation of a spectrofluorimetric method for the analysis of tolfenamic acid in pure and tablet dosage form
Tolfenamic acid (TA) is commonly used in humans and animals because of its anti‐inflammatory, antipyretic, and analgesic effects. So far, no study has been carried out to develop a validated spectrofluorimetric method for determination of TA. Therefore, the present study aimed to develop and validate a simple, accurate, rapid, economical, and precise spectrofluorimetric method to assay TA in its pure and dosage forms, and also in degraded solutions. The fluorimetric method had higher sensitivity compared with the spectrophotometric and high‐performance liquid chromatography methods and could determine the drug at the microgram level. Optimum pH of TA for maximum fluorescence intensity was 3, and its two pKa values were calculated as 1.95 and 4.05. The proposed method was validated according to the guidelines of the International Council for Harmonisation, and parameters such as linearity, range, accuracy, precision, sensitivity, robustness, specificity, and solution stability were tested. Stress‐induced degradation studies on TA did not affect the accuracy and precision of the proposed method. The results obtained indicated that the method was linear over the concentration range 0.2–0.9 × 10−3 M with good accuracy, precision, and robustness for assay of TA in its pure and its tablet dosage forms and was comparable statistically with the British Pharmacopoeia method.
- Open Access
- 27 August 2019
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 9 (46) , 26559-26571
Photolysis of carboxymethylflavin in aqueous and organic solvent: a kinetic study
This is the first study on the photolysis of carboxymethylflavin (CMF), an intermediate in the photolysis of riboflavin (RF). CMF is photodegraded by removal of side-chain to lumichrome (LC) in acid solution and to LC and lumiflavin (LF) in alkaline solution. It also undergoes alkaline hydrolysis to 1,2-dihydro-1-methyl-2-keto-3-quinoxaline carboxylic acid (KA) and 1,2,3,4-tetrahydro-1-methyl-2,3-dioxoquinoxaline (DQ) by cleavage of isoalloxazine ring. CMF degrades to LC in organic solvents. The formation of LC in acid solution and organic solvents takes place by second-order reaction and those of LC, LF, KA and DQ in alkaline solution by first-order reactions. The values of second-order rate constants for the photolysis of CMF at pH 2.0 to 7.0 are in the range of 1.13 to 2.45 M−1 s−1 and those of first-order rate constants (kobs) at pH 8.0–12.0 from 1.53 to 4.18 × 10−4 s−1 and for the formation of photoproducts from 0.37 to 16.6 × 10−5 s−1. The photolysis of CMF is enhanced, with pH, in the alkaline region since the excited state is sensitive to alkaline hydrolysis. The photolysis and fluorescence quantum yields of CMF in aqueous and organic solvents have been reported. CMF and photoproducts have been assayed spectrofluorimetrically. The mode of CMF photolysis is discussed.
- 27 August 2019
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 9 (46) , 26559-26571
Open AccessPhotolysis of carboxymethylflavin in aqueous and organic solvent: a kinetic study
This is the first study on the photolysis of carboxymethylflavin (CMF), an intermediate in the photolysis of riboflavin (RF). CMF is photodegraded by removal of side-chain to lumichrome (LC) in acid solution and to LC and lumiflavin (LF) in alkaline solution. It also undergoes alkaline hydrolysis to 1,2-dihydro-1-methyl-2-keto-3-quinoxaline carboxylic acid (KA) and 1,2,3,4-tetrahydro-1-methyl-2,3-dioxoquinoxaline (DQ) by cleavage of isoalloxazine ring. CMF degrades to LC in organic solvents. The formation of LC in acid solution and organic solvents takes place by second-order reaction and those of LC, LF, KA and DQ in alkaline solution by first-order reactions. The values of second-order rate constants for the photolysis of CMF at pH 2.0 to 7.0 are in the range of 1.13 to 2.45 M−1 s−1 and those of first-order rate constants (kobs) at pH 8.0–12.0 from 1.53 to 4.18 × 10−4 s−1 and for the formation of photoproducts from 0.37 to 16.6 × 10−5 s−1. The photolysis of CMF is enhanced, with pH, in the alkaline region since the excited state is sensitive to alkaline hydrolysis. The photolysis and fluorescence quantum yields of CMF in aqueous and organic solvents have been reported. CMF and photoproducts have been assayed spectrofluorimetrically. The mode of CMF photolysis is discussed.